High risk of QT interval prolongation and torsades de pointes associated with intravenous quinidine used for treatment of resistant malaria or babesiosis

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 8, 2012, Pages 4495-4499

  Wroblewski, Heather A ^a   Kovacs, Richard J ^b,c   Kingery, Joanna R ^c   Overholser, Brian R ^a,b   Tisdale, James E ^a,b  

^a PURDUE UNIVERSITY   (United States)

^b INDIANA UNIVERSITY   (United States)

^c INDIANA UNIVERSITY HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; AMPICILLIN; BILIRUBIN; CEFTAZIDIME; CLINDAMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; ENOXAPARIN; ESOMEPRAZOLE; ETIRACETAM; FAMOTIDINE; LEVOTHYROXINE; MAGNESIUM SULFATE; MEROPENEM; PARACETAMOL; PHENYTOIN; PIPERACILLIN PLUS TAZOBACTAM; PROPRANOLOL; QUINIDINE GLUCONATE; QUININE; SEVELAMER; SIMVASTATIN; TACROLIMUS; URSODEOXYCHOLIC ACID; VANCOMYCIN;

ACUTE KIDNEY FAILURE; ADOLESCENT; ADULT; AGED; ARTICLE; BABESIOSIS; BILIRUBIN BLOOD LEVEL; BRADYCARDIA; CHILL; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTINUOUS RENAL REPLACEMENT THERAPY; DRUG WITHDRAWAL; ELECTROCARDIOGRAM; FEMALE; HUMAN; HYPERBILIRUBINEMIA; HYPOCALCEMIA; HYPOMAGNESEMIA; HYPOTENSION; JAUNDICE; MALARIA; MALARIA FALCIPARUM; MALE; MULTIPLE ORGAN FAILURE; NAUSEA; PRIORITY JOURNAL; QT PROLONGATION; RESISTANT MALARIA; SEPSIS; TELEMETRY; TORSADE DES POINTES;

ADOLESCENT; ADULT; AGED; ANTIMALARIALS; ARRHYTHMIAS, CARDIAC; BABESIOSIS; FEMALE; HEART; HEART RATE; HUMANS; LONG QT SYNDROME; MALARIA; MALE; MIDDLE AGED; QUINIDINE; RISK FACTORS; TORSADES DE POINTES;

EID: 84864386781     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.06396-11     Document Type: Article

References (27)

1. Allen LaPointe NM, Li P. 2000. Continuous intravenous quinidine infusion for the treatment of atrial fibrillation or flutter: a case series. Am. Heart J. 139:114-121. (Pubitemid 30043633)
2. Bauman JL, et al. 1984. Torsade de pointes due to quinidine: observations in 31 patients. Am. Heart J. 107:425-430. (Pubitemid 14167715)
3. Bazett HC. 1920. An analysis of time relationships of the electrocardiogram. Heart 7:353-370.
4. Bodenhamer JE, Smilkstein MJ. 1993. Delayed cardiotoxicity following quinine overdose: a case report. J. Emerg. Med. 11:279-285. (Pubitemid 23170049)
5. Bouchaud O, Bruneel F, Schiemann R, Peytavin G, Coulaud JP. 2002. Severe cardiac toxicity due to halofantrine: importance of underlying heart disease. J. Travel Med. 9:214-215.
6. Camm AJ, et al. 2010. Guidelines for the management of atrial fibrillation. The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Europace 12:1360-1420.
7. Chiladakis J, Kalogeropoulos Arvanitis AP, Koutsogiannis N, Zagli F, Alexopoulos D. 2010. Preferred QT correction formula for the assessment of drug-induced QT interval prolongation. J. Cardiovasc. Electrophysiol. 21:905-913.
8. Claessen FAP, et al. 1998. Quinine pharmacokinetics: ototoxic and cardiotoxic effects in healthy Caucasian subjects and in patients with falciparum malaria. Trop. Med. Int. Health 3:482-489. (Pubitemid 28283574)
9. Fattinger K, Vozeh S, Ha HR, Borner M, Follath F. 1991. Population pharmacokinetics of quinidine. Br. J. Clin. Pharmacol. 31:279-286.
10. Fragasso G, et al. 2009. Cardiotoxicity after low-dose chloroquine therapy. Heart Vessels 24:385-387.
11. Fridericia LS. 1920. Die systolendauer im elektrokardiogramm bei normalen menchen und bei herzkranken. Acta Med. Scand. 53:469-486.
12. Fuster V, et al. 2001. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation - executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients with Atrial Fibrillation). Circulation 104:2118-2150. (Pubitemid 33028911)
13. Fuster V, et al. 2006. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation - executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation). Circulation 114:700-752. (Pubitemid 44252312)
14. Gillis AM, Verma A, Talajic M, Nattel S, Dorian P. 2010. CCS Atrial Fibrillation Guidelines Committee. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: rate and rhythm management. Can. J. Cardiol. 27:47-59.
15. Heist EK, Ruskin JN. 2010. Drug-induced arrhythmia. Circulation 122:1426-1435.
16. Hodak SP, et al. 1998. QT prolongation and near fatal cardiac arrhythmia after intravenous tacrolimus administration: a case report. Transplantation 66:535-537. (Pubitemid 28415384)
17. Hodges M. 1997. Rate correction of the QT interval. Cardiac Electrophysiol. Rev. 1:360-363. (Pubitemid 127503231)
18. Mali S, Kachur SP, Arguin PM. 2012. Malaria surveillance - United States, 2010. MMWR Surveill. Summ. 61:1-17.
19. Martin ES, Rogalski K, Black JN. 1997. Quinine may trigger torsades de pointes during astemizole therapy. Pacing Clin. Electrophysiol. 20:2024-2025.
20. Ochs HR, Greenblatt DJ, Woo E. 1980. Clinical pharmacokinetics of quinidine. Clin. Pharmacokinet. 5:150-169.
21. Ramírez A, Galván JM. 2007. Torsades-de-pointes-type ventricular tachycardia in a patient with digitalis intoxication under chronic treatment with quinine sulfate. Med. Intensiva 31:106-107. (Pubitemid 46649147)
22. Roden DM, Thompson KA, Hoffman BF, Woosley RL. 1986. Clinical features and basic mechanisms of quinidine-induced arrhythmias. J. Am. Coll. Cardiol. 8(Suppl A):73A-78A. (Pubitemid 16064081)
23. Setty S, Khalil Z, Schori P, Azar M, Ferrieri P. 2003. Babesiosis. Two atypical cases from Minnesota and a review. Am. J. Clin. Pathol. 120:554-559. (Pubitemid 37186049)
24. Tisdale JE. 2010. Ventricular arrhythmias, p 485-515. In Tisdale JE, Miller DA (ed), Drug-induced diseases. Prevention, detection and management, 2nd ed. American Society of Health-Systems Pharmacists, Bethesda, MD.
25. Wann LS, et al. 2011. 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (updating the 2006 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 123:104-123.
26. White N, Looareesuwan S, Warrell D. 1983. Quinine and quinidine: a comparison of EKG effects during the treatment of malaria. J. Cardiovasc. Pharmacol. 5:173-175. (Pubitemid 13163092)
27. World Health Organization. 2010. Guidelines for the treatment of malaria, 2nd ed. World Health Organization, Geneva, Switzerland.